Sign up now!
Don't show this again
Sweepstakes Rules

We’re glad you’re enjoying Poultry Health Today.
Access is free but you’ll need to register to view more content.
Already registered? Sign In
Tap to download the app
REPORTSCollect articles and features into your own report to read later, print or share with others

Create a New Report


Read Later

Create a new report

Report title (required) Brief description (optional)
follow us

You must be logged in to edit your profile.

Sponsored by Zoetis

Sponsored By Zoetis

Cookson Cropped

Field trials show practical, economic benefits of E. coli vaccine in broilers

Recent studies on two continents have demonstrated that a modified-live vaccine reduced losses from Escherichia coli in broilers, even when the disease challenge was strong.1

The studies were conducted on farms in the US and North Africa. “There were a variety of conditions, but one thing in common was a higher than normal E. coli challenge,” said Kalen Cookson, DVM, MAM, a technical services veterinarian for Zoetis.

In the US trial, investigators administered the vaccine Poulvac® E. coli to more than 4 million broilers at hatch. They then compared performance to unvaccinated chicks hatched the previous week that were treated in ovo with the antibiotic gentamycin.

Chicks that received Poulvac E. coli and no gentamycin had a better adjusted feed conversion, lower mortality after week 1 and fewer condemnations compared to controls, yielding a US 0.51 cents (€ 0.39) advantage per pound. They also had significantly less disease and needed less antibiotic treatment and for a shorter duration of time, he said.

One of the field trials in North Africa involved two broiler houses with 8,000 birds each on a farm with high E. coli mortality. Investigators treated all birds with an antibiotic in ovo, and then vaccinated one house with Poulvac E. coli at 3 days of age. The other house was not vaccinated but was treated with enrofloxacin for the first 3 days of life.

At 40 days of age, vaccinated birds had lower total mortality, better bodyweight and a better feed-conversion ratio (FCR) compared to unvaccinated birds, Cookson said.

In another field trial in North Africa involving 15 different farms with a history of E. coli colibacillosis, no preventive in ovo or in-feed antibiotics were administered. Compared to controls, broilers vaccinated with Poulvac E. coli had an overall better average daily gain and FCR and fewer E. coli lesions. When antibiotic treatment was needed, it was necessary for a shorter duration, Cookson said.

See full article.

1 Cookson K, et al. A modified live Escherichia coli vaccine reduces mortality and colibacillosis in broiler field trails. 2013 World Veterinary Poultry Association Conference, Nantes, France. FDAH Study #B510-09-RFt.R (US trial report) and FDAH Study #3113C- 39-10-347 (Moroccan trial report).


Posted on November 13, 2014

tags: ,

You must be logged in to edit your profile.

Google Translate is provided on this website as a reference tool. However, Poultry Health Today and its sponsor and affiliates do not guarantee in any way the accuracy of the translated content and are not responsible for any event resulting from the use of the translation provided by Google. By choosing a language other than English from the Google Translate menu, the user agrees to withhold all liability and/or damage that may occur to the user by depending on or using the translation by Google.